Hypertension Clinical Trials

Showing 1141-1160 of 1,710 trials

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

NCT00170963

This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication

Hypertension

Novartis1,018 participantsStarted Oct 2004

Investigative Centers, Germany • Basel, Switzerland

COMPLETEDPhase 3

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

NCT00219063

To compare the aliskiren regimen versus the ramipril regimen on reduction in Blood Pressure.

Hypertension

Novartis844 participantsStarted Feb 2005

East Hanover, New Jersey, United States

COMPLETEDPhase 1

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

NCT02094924

This study is required to confirm the suitability of a candidate FDC of 16mg candesartan cilexetil/12.5mg HCTZ (GSK587323) formulation for further development and provide data to allow the design of a future pivotal bioequivalence study. This study aims to determine the relative bioavailability of a FDC tablet formulation of 16mg candesartan cilexetil/12.5mg HCTZ relative to the reference product of same fixed dose combination (16mg candesartan cilexetil/12.5mg HCTZ) in healthy adult humans. This will be an open-label, randomised, single dose, two-way crossover study. Each subject will participate in two treatment periods and will be randomized to one of two sequences and administered one of the two treatments, A or B, as per the randomization schedule. The two treatment periods will be separated by a washout period of 7 to 14 days to ensure the candesartan and HCTZ have been effectively eliminated from the subject between dosing occasions. The study will enroll 16 healthy subjects to ensure that 14 subjects complete the study as planned.

Hypertension

GlaxoSmithKline16 participantsStarted Apr 2014

Hyderabad, India

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

Related Searches

Study of a Community Based Approach to Control Cardiovascular Risk Factors in India

Yoga as a Supportive Therapy for Patients With Hypertension

Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation

Evaluation of Lung Doppler Signals in Pulmonary Hypertension

Improving Heart Health in Appalachia

DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension

Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial Stiffness

Effects of Blackberry-derived Polyphenols on Cardiovascular Risk in Adults